US Stock MarketDetailed Quotes

Recursion Pharmaceuticals (RXRX)

Watchlist
  • 3.050
  • -0.100-3.17%
Close May 13 16:00 ET
  • 3.070
  • +0.020+0.66%
Post 20:01 ET
1.62BMarket Cap-2.63P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Recursion Pharmaceuticals (RXRX) Income Statement

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Mar 31, 2026
(FY)Dec 31, 2025
(Q4)Dec 31, 2025
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
Total revenue
-57.48%6.3M
26.96%74.26M
683.66%35.35M
-80.89%4.98M
32.62%19.1M
9.84%14.82M
33.30%58.49M
-57.54%4.51M
158.19%26.08M
30.76%14.4M
Operating revenue
-57.48%6.3M
26.96%74.26M
683.66%35.35M
-80.89%4.98M
32.62%19.1M
9.84%14.82M
33.30%58.49M
-57.54%4.51M
158.19%26.08M
30.76%14.4M
Cost of revenue
-42.78%12.49M
56.84%70.95M
11.58%14.28M
21.59%14.69M
119.17%20.16M
95.50%21.83M
6.22%45.24M
29.48%12.79M
11.05%12.08M
-1.95%9.2M
Gross profit
11.72%-6.19M
-75.07%3.3M
354.45%21.08M
-169.30%-9.7M
-120.33%-1.06M
-401.55%-7.01M
927.93%13.25M
-1,214.80%-8.28M
1,906.84%14M
218.54%5.21M
Operating expense
-33.65%122.32M
32.34%651.44M
-26.26%129.41M
44.63%162.5M
65.65%175.17M
86.85%184.36M
40.10%492.25M
76.06%175.49M
13.75%112.36M
26.87%105.75M
Selling and administrative expenses
-36.70%34.59M
-0.90%176.59M
-56.39%33.66M
10.25%41.63M
46.56%46.65M
74.00%54.65M
60.78%178.18M
153.42%77.19M
29.31%37.76M
12.52%31.83M
-General and administrative expense
-36.70%34.59M
-0.90%176.59M
-56.39%33.66M
10.25%41.63M
46.56%46.65M
74.00%54.65M
60.78%178.18M
153.42%77.19M
29.31%37.76M
12.52%31.83M
Research and development costs
-32.20%87.9M
51.16%475.27M
-2.43%95.94M
62.28%121.06M
74.00%128.64M
91.88%129.63M
30.34%314.42M
41.52%98.33M
6.56%74.6M
34.27%73.93M
Other operating expenses
-334.25%-171K
-21.08%-425K
-434.29%-187K
---192K
-823.08%-120K
124.09%73K
49.79%-351K
86.89%-35K
----
-1,200.00%-13K
Operating profit
32.85%-128.51M
-35.31%-648.13M
41.05%-108.33M
-75.08%-172.2M
-75.28%-176.23M
-98.64%-191.37M
-36.83%-479M
-85.76%-183.77M
1.20%-98.35M
-23.04%-100.54M
Net non-operating interest income expense
11.15%5.61M
47.88%20.98M
55.87%6.26M
43.81%4.71M
72.81%4.96M
25.37%5.05M
-25.41%14.19M
-10.70%4.02M
-33.91%3.27M
-41.76%2.87M
Non-operating interest income
7.29%5.96M
44.61%22.79M
35.22%6.25M
44.80%5.54M
66.66%5.44M
37.30%5.56M
-17.57%15.76M
2.17%4.62M
-23.13%3.83M
-34.11%3.27M
Non-operating interest expense
-31.10%350K
15.14%1.81M
-101.82%-11K
50.63%833K
21.83%480K
2,440.00%508K
1,520.62%1.57M
2,226.92%605K
2,112.00%553K
1,415.38%394K
Other net income (expense)
104.80%784K
-59,236.67%-17.74M
-805.50%-6.03M
983.00%5.25M
-61.48%-633K
-10,304.38%-16.33M
102.76%30K
132.55%854K
-137.57%-594K
-787.72%-392K
Other non- operating income (expenses)
104.80%784K
-59,236.67%-17.74M
-805.50%-6.03M
983.00%5.25M
-61.48%-633K
-10,304.38%-16.33M
102.76%30K
132.55%854K
-137.57%-594K
-787.72%-392K
Income before tax
39.74%-122.11M
-38.75%-644.9M
39.57%-108.1M
-69.58%-162.25M
-75.29%-171.9M
-119.90%-202.65M
-39.94%-464.79M
-84.32%-178.9M
-2.86%-95.68M
-27.81%-98.06M
Income tax
-2,813.92%-4.6M
87.93%-136K
185.71%20K
-98.20%3K
0
79.72%-158K
72.26%-1.13M
100.17%7K
167K
-523K
Net income
41.97%-117.5M
-39.06%-644.76M
39.57%-108.12M
-69.29%-162.25M
-76.23%-171.9M
-121.60%-202.49M
-41.33%-463.66M
-92.38%-178.91M
-3.04%-95.84M
-27.13%-97.54M
Net income continuous Operations
41.97%-117.5M
-39.06%-644.76M
39.57%-108.12M
-69.29%-162.25M
-76.23%-171.9M
-121.60%-202.49M
-41.33%-463.66M
-92.38%-178.91M
-3.04%-95.84M
-27.13%-97.54M
Minority interest income
Net income attributable to the parent company
41.97%-117.5M
-39.06%-644.76M
39.56%-108.12M
-69.29%-162.25M
-76.23%-171.9M
-121.60%-202.49M
-41.33%-463.66M
-92.38%-178.91M
-3.04%-95.84M
-27.13%-97.54M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
41.97%-117.5M
-39.06%-644.76M
39.56%-108.12M
-69.29%-162.25M
-76.23%-171.9M
-121.60%-202.49M
-41.33%-463.66M
-92.38%-178.91M
-3.04%-95.84M
-27.13%-97.54M
Basic earnings per share
56.00%-0.22
14.79%-1.44
60.38%-0.21
-5.88%-0.36
-2.50%-0.41
-28.21%-0.5
-6.96%-1.69
-26.19%-0.53
20.93%-0.34
-5.26%-0.4
Diluted earnings per share
56.00%-0.22
14.79%-1.44
60.38%-0.21
-5.88%-0.36
-2.50%-0.41
-28.21%-0.5
-6.96%-1.69
-26.19%-0.53
20.93%-0.34
-5.26%-0.4
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
(Q1)Mar 31, 2026(FY)Dec 31, 2025(Q4)Dec 31, 2025(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024
Total revenue -57.48%6.3M26.96%74.26M683.66%35.35M-80.89%4.98M32.62%19.1M9.84%14.82M33.30%58.49M-57.54%4.51M158.19%26.08M30.76%14.4M
Operating revenue -57.48%6.3M26.96%74.26M683.66%35.35M-80.89%4.98M32.62%19.1M9.84%14.82M33.30%58.49M-57.54%4.51M158.19%26.08M30.76%14.4M
Cost of revenue -42.78%12.49M56.84%70.95M11.58%14.28M21.59%14.69M119.17%20.16M95.50%21.83M6.22%45.24M29.48%12.79M11.05%12.08M-1.95%9.2M
Gross profit 11.72%-6.19M-75.07%3.3M354.45%21.08M-169.30%-9.7M-120.33%-1.06M-401.55%-7.01M927.93%13.25M-1,214.80%-8.28M1,906.84%14M218.54%5.21M
Operating expense -33.65%122.32M32.34%651.44M-26.26%129.41M44.63%162.5M65.65%175.17M86.85%184.36M40.10%492.25M76.06%175.49M13.75%112.36M26.87%105.75M
Selling and administrative expenses -36.70%34.59M-0.90%176.59M-56.39%33.66M10.25%41.63M46.56%46.65M74.00%54.65M60.78%178.18M153.42%77.19M29.31%37.76M12.52%31.83M
-General and administrative expense -36.70%34.59M-0.90%176.59M-56.39%33.66M10.25%41.63M46.56%46.65M74.00%54.65M60.78%178.18M153.42%77.19M29.31%37.76M12.52%31.83M
Research and development costs -32.20%87.9M51.16%475.27M-2.43%95.94M62.28%121.06M74.00%128.64M91.88%129.63M30.34%314.42M41.52%98.33M6.56%74.6M34.27%73.93M
Other operating expenses -334.25%-171K-21.08%-425K-434.29%-187K---192K-823.08%-120K124.09%73K49.79%-351K86.89%-35K-----1,200.00%-13K
Operating profit 32.85%-128.51M-35.31%-648.13M41.05%-108.33M-75.08%-172.2M-75.28%-176.23M-98.64%-191.37M-36.83%-479M-85.76%-183.77M1.20%-98.35M-23.04%-100.54M
Net non-operating interest income expense 11.15%5.61M47.88%20.98M55.87%6.26M43.81%4.71M72.81%4.96M25.37%5.05M-25.41%14.19M-10.70%4.02M-33.91%3.27M-41.76%2.87M
Non-operating interest income 7.29%5.96M44.61%22.79M35.22%6.25M44.80%5.54M66.66%5.44M37.30%5.56M-17.57%15.76M2.17%4.62M-23.13%3.83M-34.11%3.27M
Non-operating interest expense -31.10%350K15.14%1.81M-101.82%-11K50.63%833K21.83%480K2,440.00%508K1,520.62%1.57M2,226.92%605K2,112.00%553K1,415.38%394K
Other net income (expense) 104.80%784K-59,236.67%-17.74M-805.50%-6.03M983.00%5.25M-61.48%-633K-10,304.38%-16.33M102.76%30K132.55%854K-137.57%-594K-787.72%-392K
Other non- operating income (expenses) 104.80%784K-59,236.67%-17.74M-805.50%-6.03M983.00%5.25M-61.48%-633K-10,304.38%-16.33M102.76%30K132.55%854K-137.57%-594K-787.72%-392K
Income before tax 39.74%-122.11M-38.75%-644.9M39.57%-108.1M-69.58%-162.25M-75.29%-171.9M-119.90%-202.65M-39.94%-464.79M-84.32%-178.9M-2.86%-95.68M-27.81%-98.06M
Income tax -2,813.92%-4.6M87.93%-136K185.71%20K-98.20%3K079.72%-158K72.26%-1.13M100.17%7K167K-523K
Net income 41.97%-117.5M-39.06%-644.76M39.57%-108.12M-69.29%-162.25M-76.23%-171.9M-121.60%-202.49M-41.33%-463.66M-92.38%-178.91M-3.04%-95.84M-27.13%-97.54M
Net income continuous Operations 41.97%-117.5M-39.06%-644.76M39.57%-108.12M-69.29%-162.25M-76.23%-171.9M-121.60%-202.49M-41.33%-463.66M-92.38%-178.91M-3.04%-95.84M-27.13%-97.54M
Minority interest income
Net income attributable to the parent company 41.97%-117.5M-39.06%-644.76M39.56%-108.12M-69.29%-162.25M-76.23%-171.9M-121.60%-202.49M-41.33%-463.66M-92.38%-178.91M-3.04%-95.84M-27.13%-97.54M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 41.97%-117.5M-39.06%-644.76M39.56%-108.12M-69.29%-162.25M-76.23%-171.9M-121.60%-202.49M-41.33%-463.66M-92.38%-178.91M-3.04%-95.84M-27.13%-97.54M
Basic earnings per share 56.00%-0.2214.79%-1.4460.38%-0.21-5.88%-0.36-2.50%-0.41-28.21%-0.5-6.96%-1.69-26.19%-0.5320.93%-0.34-5.26%-0.4
Diluted earnings per share 56.00%-0.2214.79%-1.4460.38%-0.21-5.88%-0.36-2.50%-0.41-28.21%-0.5-6.96%-1.69-26.19%-0.5320.93%-0.34-5.26%-0.4
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions --Unqualified Opinion--------Unqualified Opinion------
Market Insights
No. Symbol 20D % Chg
Sample Name
Sample Code
 +21.52%
Sample Name
Sample Code
 +18.03%
Sample Name
Sample Code
 +17.02%
4
United States Oil Fund LP
USO
+15.87%
5
Powershares Db Multi-Sector Commodi Powershares Db Oil Fund
DBO
+11.63%
View More
China Concept Stocks
No. Symbol 5D % Chg
Sample Name
Sample Code
 +12.98%
Sample Name
Sample Code
 +10.85%
Sample Name
Sample Code
 +10.04%
4
Kingsoft Cloud
KC
+7.76%
5
Hesai
HSAI
+7.08%
View More
Middle East conflict spreads to the stock market! How should investors respond?
According to Axios, on Sunday local time, Trump rejected Iran's latest ceasefire proposal, prompting a sharp response from Iran: no one woul Show More
Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.
Hormuz, Term Structure and USO: Navigating the Energy Storm

- No more -